Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
Despite the progress in fighting against infectious diseases of bacterial origin, the incidence of generalized forms of meningococcal infection (GFMI) remains a topical public health problem not only in countries with historical high incidence, but also in countries considered to be relatively «secu...
Saved in:
| Main Authors: | M. V. Abramtseva, A. P. Tarasov, T. I. Nemirovskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/36 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01) -
Current Meningococcal Vaccines: Advantages and Disadvantages and New Challenges
by: N. N. Kostyukova, et al.
Published: (2016-08-01) -
Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01) -
An overview of the meningococcal disease and impact of the quadrivalent meningococcal conjugate vaccine
by: Asmaa Alrobai, et al.
Published: (2021-12-01) -
Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age
by: V. V. Romanenko, et al.
Published: (2023-11-01)